DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,244 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,126,059 | +4.5% | 12,512 | +4.4% | 0.06% | +1.6% |
Q1 2024 | $2,992,834 | +11.9% | 11,985 | +3.6% | 0.06% | +1.6% |
Q4 2023 | $2,675,386 | -17.4% | 11,565 | -11.4% | 0.06% | -26.2% |
Q3 2023 | $3,239,980 | +22.9% | 13,059 | +18.9% | 0.08% | +25.4% |
Q2 2023 | $2,635,235 | -4.8% | 10,980 | -0.0% | 0.07% | -11.8% |
Q1 2023 | $2,767,681 | -14.7% | 10,981 | -10.2% | 0.08% | -20.0% |
Q4 2022 | $3,244,784 | -4.1% | 12,225 | -6.7% | 0.10% | -18.1% |
Q3 2022 | $3,384,000 | +11.6% | 13,103 | +9.5% | 0.12% | +12.6% |
Q2 2022 | $3,033,000 | -11.7% | 11,962 | +2.2% | 0.10% | 0.0% |
Q1 2022 | $3,433,000 | -6.9% | 11,703 | +4.4% | 0.10% | -8.8% |
Q4 2021 | $3,687,000 | +12.9% | 11,207 | +4.4% | 0.11% | 0.0% |
Q3 2021 | $3,267,000 | +20.2% | 10,730 | +6.0% | 0.11% | +4.6% |
Q2 2021 | $2,718,000 | +27.2% | 10,127 | +6.7% | 0.11% | +14.9% |
Q1 2021 | $2,136,000 | +7.1% | 9,492 | +5.8% | 0.09% | 0.0% |
Q4 2020 | $1,994,000 | -6.9% | 8,974 | -9.8% | 0.09% | -18.3% |
Q3 2020 | $2,141,000 | +24.2% | 9,944 | +2.0% | 0.12% | +10.6% |
Q2 2020 | $1,724,000 | +36.1% | 9,752 | +6.6% | 0.10% | -4.6% |
Q1 2020 | $1,267,000 | +19.3% | 9,151 | +32.3% | 0.11% | +39.7% |
Q4 2019 | $1,062,000 | +8.4% | 6,918 | +2.0% | 0.08% | -3.7% |
Q3 2019 | $980,000 | +6.6% | 6,785 | +5.5% | 0.08% | +2.5% |
Q2 2019 | $919,000 | +1.3% | 6,431 | -6.3% | 0.08% | +2.6% |
Q1 2019 | $907,000 | +48.9% | 6,867 | +16.2% | 0.08% | +35.1% |
Q4 2018 | $609,000 | -8.4% | 5,908 | -3.5% | 0.06% | -16.2% |
Q3 2018 | $665,000 | +27.4% | 6,124 | +15.7% | 0.07% | +17.2% |
Q2 2018 | $522,000 | +14.5% | 5,294 | +13.8% | 0.06% | +9.4% |
Q1 2018 | $456,000 | +48.5% | 4,653 | +40.8% | 0.05% | +43.2% |
Q4 2017 | $307,000 | +40.2% | 3,304 | +29.3% | 0.04% | +27.6% |
Q3 2017 | $219,000 | +1.4% | 2,555 | -0.2% | 0.03% | -6.5% |
Q2 2017 | $216,000 | -8.1% | 2,560 | -6.9% | 0.03% | -11.4% |
Q1 2017 | $235,000 | +16.3% | 2,751 | +6.8% | 0.04% | +16.7% |
Q3 2016 | $202,000 | -9.8% | 2,576 | +16.4% | 0.03% | -9.1% |
Q2 2016 | $224,000 | +14.9% | 2,213 | +7.7% | 0.03% | 0.0% |
Q1 2016 | $195,000 | +14.0% | 2,054 | +11.5% | 0.03% | 0.0% |
Q4 2015 | $171,000 | +11.8% | 1,842 | +2.8% | 0.03% | -5.7% |
Q3 2015 | $153,000 | +11.7% | 1,791 | +12.1% | 0.04% | +16.7% |
Q2 2015 | $137,000 | -1.4% | 1,598 | -2.2% | 0.03% | -11.8% |
Q1 2015 | $139,000 | -31.9% | 1,634 | -31.5% | 0.03% | -33.3% |
Q4 2014 | $204,000 | +71.4% | 2,384 | +52.7% | 0.05% | +30.8% |
Q3 2014 | $119,000 | -3.3% | 1,561 | 0.0% | 0.04% | -9.3% |
Q2 2014 | $123,000 | -10.9% | 1,561 | -15.0% | 0.04% | -23.2% |
Q1 2014 | $138,000 | -4.2% | 1,836 | -1.8% | 0.06% | +7.7% |
Q4 2013 | $144,000 | -16.8% | 1,870 | -25.2% | 0.05% | -29.7% |
Q3 2013 | $173,000 | +22.7% | 2,499 | +12.4% | 0.07% | +1.4% |
Q2 2013 | $141,000 | – | 2,224 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CORTLAND ASSOCIATES INC/MO | 752,930 | $52,193,000 | 11.19% |
RobecoSam USA, Inc. | 119,035 | $8,252,000 | 10.58% |
Consulta Ltd | 689,081 | $47,767,000 | 7.32% |
Robeco Schweiz AG | 978,700 | $68,382,000 | 5.73% |
Five Oceans Asset Management LTD | 255,259 | $17,695,000 | 5.22% |
GENERATION INVESTMENT MANAGEMENT LLP | 3,825,008 | $265,150,000 | 5.04% |
ASHMORE WEALTH MANAGEMENT LLC | 3,300,000 | $228,756,000 | 4.98% |
DAVIS-REA LTD. | 89,193 | $6,183,000 | 4.79% |
CADINHA & CO LLC | 332,935 | $23,079,000 | 4.63% |
VIKING GLOBAL INVESTORS LP | 11,436,737 | $792,794,000 | 4.38% |